IOT Innovotech Inc

Innovotech Inc. (TSX VENTURE:IOT):

Pharmax Limited has been granted Health Canada approval for two new
disinfectants for use on hard surfaces in hospitals and other healthcare sites
requiring a high level of disinfection. Innovotech's patented plate technology
was used to rapidly develop the scientific data required for approval.


"Innovotech's technology helped to provide the required data in 1/10th the time
that would have been needed using current standards. Now that our technology has
been accepted by a recognized regulatory agency it will allow future new
products to gain approval and be brought to market more quickly" states Ken
Boutilier, President, Innovotech Inc. "This is important because growing
bacterial resistance to current disinfectants requires faster and more cost
effective introduction of new products."


"Health Canada approval for these unique products confirms our leadership
position as a premium provider of products for the control of microorganisms,
particularly in a biofilm state," said Gary Hodgins, President of Pharmax
Limited. "Innovotech expertise has allowed us to bring innovative products to
market in timely and creative ways."


About Innovotech Inc:

Innovotech is a product development company focusing on the development of
solutions to medical, agricultural and industrial problems caused by microbial
biofilms. Biofilms are protected communities of microorganisms which are very
common and very difficult to treat due to their inherent resistance. They have
been implicated in a host of devastating infections in agriculture, human health
and industry.


About Pharmax Limited:

Pharmax Limited is a Canada-based global healthcare manufacturer specializing in
chemistry to destabilize and eradicate biofilms in a wide variety of
applications.


This document may contain forward-looking statements that are predictive in
nature and subject to risks and uncertainties that cannot be predicted or
quantified; consequently, actual results may differ materially from past results
and those expressed or implied by any forward-looking statements. Specifically,
it may be that not all of the results of trials using Innovotech products will
be as successful as they were in the Pharmax trials. Should known or unknown
risks or uncertainties materialize, or should management's assumptions prove
inaccurate, actual results could vary materially from those anticipated. The
Company undertakes no obligation to publicly make or update any forward-looking
statements, except as required by applicable law.

Innovotech (TSXV:IOT)
Historical Stock Chart
From Jun 2024 to Jul 2024

Innovotech (TSXV:IOT)
Historical Stock Chart
From Jul 2023 to Jul 2024